CONMED Corporation revised earnings guidance for the full year 2024. For the period, the company's revenue is expected to be between $1.330 billion and $1.355 billion, compared to the prior guidance range of between $1.340 billion and $1.365 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
75.5 USD | +1.29% | +7.34% | -31.06% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.06% | 2.33B | |
-4.72% | 182B | |
+3.96% | 114B | |
-2.93% | 68.38B | |
+6.30% | 52.46B | |
+8.02% | 44.25B | |
+7.97% | 43.55B | |
+26.18% | 32.69B | |
+17.46% | 26.73B | |
+0.57% | 25.79B |
- Stock Market
- Equities
- CNMD Stock
- News CONMED Corporation
- CONMED Corporation Revises Earnings Guidance for the Full Year 2024